Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial.
about
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infectionAntiretrovirals for reducing the risk of mother-to-child transmission of HIV infectionEffectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in womenCan context justify an ethical double standard for clinical research in developing countries?Effectiveness of non-nucleoside reverse-transcriptase inhibitor-based antiretroviral therapy in women previously exposed to a single intrapartum dose of nevirapine: a multi-country, prospective cohort studyEfficacy of short-course AZT plus 3TC to reduce nevirapine resistance in the prevention of mother-to-child HIV transmission: a randomized clinical trialHIV-1 drug resistance emergence among breastfeeding infants born to HIV-infected mothers during a single-arm trial of triple-antiretroviral prophylaxis for prevention of mother-to-child transmission: a secondary analysisElimination of mother-to-child transmission of HIV: lessons learned from success in Thailand.Nonparametric receiver operating characteristic-based evaluation for survival outcomes.The impact of Fogarty International Center research training programs on public health policy and program development in Kenya and Uganda.Systematic review of the efficacy of antiretroviral therapies for reducing the risk of mother-to-child transmission of HIV infection.18-month effectiveness of short-course antiretroviral regimens combined with alternatives to breastfeeding to prevent HIV mother-to-child transmission.Survival of infants born to HIV-positive mothers, by feeding modality, in Rakai, Uganda.Reuse of single-dose nevirapine in subsequent pregnancies for the prevention of mother-to-child HIV transmission in Lusaka, Zambia: a cohort study.Nevirapine resistance and breast-milk HIV transmission: effects of single and extended-dose nevirapine prophylaxis in subtype C HIV-infected infantsHIV: mother-to-child transmissionThe contribution of family planning towards the prevention of vertical HIV transmission in Uganda.RT-SHIV subpopulation dynamics in infected macaques during anti-HIV therapy.Non-adherence to the single dose nevirapine regimen for the prevention of mother-to-child transmission of HIV in Bindura town, Zimbabwe: a cross-sectional analytic study.Persistent minority K103N mutations among women exposed to single-dose nevirapine and virologic response to nonnucleoside reverse-transcriptase inhibitor-based therapy.Incidence and risk factors of severe adverse events with nevirapine-based antiretroviral therapy in HIV-infected women. MTCT-Plus program, Abidjan, Côte d'Ivoire.Temporal and lateral dynamics of HIV shedding and elevated sodium in breast milk among HIV-positive mothers during the first 4 months of breast-feeding.Immunogenicity of viral vector, prime-boost SIV vaccine regimens in infant rhesus macaques: attenuated vesicular stomatitis virus (VSV) and modified vaccinia Ankara (MVA) recombinant SIV vaccines compared to live-attenuated SIV.Protein adducts as prospective biomarkers of nevirapine toxicity.Safety and effectiveness of antiretroviral therapies for HIV-infected women and their infants and children: protocol for a systematic review and network meta-analysisPromising outcomes of a national programme for the prevention of Mother-to-Child HIV transmission in Addis Ababa: a retrospective study.Decay of K103N mutants in cellular DNA and plasma RNA after single-dose nevirapine to reduce mother-to-child HIV transmission.Decreased emergence of HIV-1 drug resistance mutations in a cohort of Ugandan women initiating option B+ for PMTCT.Risk factors associated with low CD4+ lymphocyte count among HIV-positive pregnant women in NigeriaAddressing missing data in clinical trialsEffectiveness of multidrug antiretroviral regimens to prevent mother-to-child transmission of HIV-1 in routine public health services in Cameroon.Detection of HIV-1 drug resistance in women following administration of a single dose of nevirapine: comparison of plasma RNA to cellular DNA by consensus sequencing and by oligonucleotide ligation assay.Triple-antiretroviral prophylaxis to prevent mother-to-child HIV transmission through breastfeeding--the Kisumu Breastfeeding Study, Kenya: a clinical trial.HIV: prevention of mother-to-child transmission.Association of HIV diversity and survival in HIV-infected Ugandan infants.Antiretroviral drugs for preventing mother-to-child transmission of HIV in sub-Saharan Africa: balancing efficacy and infant toxicity.Early weaning of HIV-exposed uninfected infants and risk of serious gastroenteritis: Findings from two perinatal HIV prevention trials in Kampala, Uganda.Direct regression models for longitudinal rates of change.The cost effectiveness of home-based provision of antiretroviral therapy in rural Uganda.Addition of 7 days of zidovudine plus lamivudine to peripartum single-dose nevirapine effectively reduces nevirapine resistance postpartum in HIV-infected mothers in Malawi.
P2860
Q24235500-D263A5AE-8E6C-41BE-928A-305E990F5144Q24243146-547404E2-5E28-47B9-A048-EDA6145352CDQ24629582-8CE91673-A1F1-49A9-B349-B1B2F5CDF237Q24811021-ADB76AE0-777F-44DC-B29F-B4139E0F4F43Q28472889-AC03D34F-9831-4C3B-9258-CC9CDE81B53FQ28476329-26D6D1D8-054B-4DE8-9A04-43A2F0C71EEAQ28477542-AB1EB2B1-E5B6-4123-94F1-05A0CF0629E8Q30236015-AF60196A-3B52-4AB9-9B3F-E46A5F19A286Q30542862-5A099542-C2CE-48BD-BEAE-CD0B8BBE7BDCQ30558707-58544CB1-F3D5-43BC-BA6A-A8B2B4BB5073Q33284135-FEC9AA50-3D15-4072-B689-21FF66BBE473Q33320539-EB914669-A4E2-4DEC-952E-64995172686EQ33391079-E148F1A3-1674-48C1-91F8-E7C1609DEE43Q33396553-2444C943-744E-4360-9CB8-D104A2C45F76Q33396950-632825FD-396D-40CB-8082-D5C94EF330D1Q33446714-157ADBE9-951C-4709-986F-00EF31660E05Q33514838-9066B93D-D528-48C8-8A7A-1E2EFE4A8531Q33514943-347EE227-92FC-4672-B04E-083F1A00BB12Q33567227-85DC6510-97AD-4C55-9580-C3FD4DF78427Q33605273-2DEB96BC-D0C0-4224-9D34-86A4D69AE140Q33615251-D08674B2-7E38-488F-8037-3A67919496BEQ33652864-3D763ADD-795D-444F-8D00-1EE2745064B7Q33653655-F316B938-6533-42F1-A1E5-461DCB7E75D4Q33681307-A52794C1-1099-4960-AAA8-E060759EA323Q33688187-C8FA0E50-2057-4DDB-920E-65914600BED4Q33688520-BFFD7781-DBB1-4E51-8725-B599A769E76DQ33739249-5BD41935-7558-464F-A797-AA5B62E05E52Q33745946-9F696C20-E88D-47FA-98DE-C101AAAD10BEQ33764938-FDBC77EE-1E6E-407A-9ABE-CDF0DF16F344Q33795600-A9E3A2A5-B765-43EA-A7AC-B55316E21243Q33818426-45C72826-AC54-48B6-81C9-3CD039CBB0DDQ33827080-96A841BC-69F5-4599-B76A-F103E9D4F5D5Q33863552-919F6245-139F-4BC6-B019-644D23306DA7Q33866493-02162A68-06CD-4340-9DD4-73BC07C1A357Q33886570-F80F5FAB-92E1-4B88-AB94-96CE94D2A451Q33897042-961CC81E-2662-4C87-B18F-F1A0938306CBQ33926411-617297EC-CDF1-4D18-B5E0-7B58DFE226EEQ33967114-47E3AB59-D41F-4F2A-8F67-D4877E0C52EFQ34029513-0DEA217A-746C-439E-82F5-994B57B3BDD6Q34033166-511FB090-27AF-4F03-B36A-FB71C28508F1
P2860
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Intrapartum and neonatal singl ...... e HIVNET 012 randomised trial.
@en
type
label
Intrapartum and neonatal singl ...... e HIVNET 012 randomised trial.
@en
prefLabel
Intrapartum and neonatal singl ...... e HIVNET 012 randomised trial.
@en
P2093
P921
P1433
P1476
Intrapartum and neonatal singl ...... he HIVNET 012 randomised trial
@en
P2093
Anthony Mwatha
Clemensia Nakabiito
Constance Ducar
Corey Duefield
Danstan Bagenda
Dorothy Bray
Francis Mmiro
Joseph Sherman
Laura A Guay
Lynda Emel
P304
P356
10.1016/S0140-6736(03)14341-3
P407
P577
2003-09-01T00:00:00Z